CNY 8.7
(0.12%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -2.65 Billion CNY | -4.52% |
2022 | -2.53 Billion CNY | -203.48% |
2021 | -836.27 Million CNY | -12.14% |
2020 | -745.75 Million CNY | -401.69% |
2019 | 247.19 Million CNY | -8.27% |
2018 | 269.47 Million CNY | 285.74% |
2017 | 69.85 Million CNY | 150.38% |
2016 | -138.66 Million CNY | 36.61% |
2015 | -218.73 Million CNY | -233.27% |
2014 | -65.63 Million CNY | -161.65% |
2013 | -25.08 Million CNY | -201.93% |
2012 | 24.61 Million CNY | -38.24% |
2011 | 39.84 Million CNY | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q3 | -2.16 Billion CNY | -43.9% |
2024 Q1 | -1.82 Billion CNY | 31.09% |
2024 Q2 | -1.2 Billion CNY | 33.82% |
2023 Q2 | -2.26 Billion CNY | 15.77% |
2023 Q4 | -2.65 Billion CNY | -1.84% |
2023 FY | -2.65 Billion CNY | -4.52% |
2023 Q1 | -2.68 Billion CNY | -5.92% |
2023 Q3 | -2.6 Billion CNY | -15.03% |
2022 FY | -2.53 Billion CNY | -203.48% |
2022 Q3 | -2.5 Billion CNY | -138.01% |
2022 Q1 | -2.24 Billion CNY | -168.24% |
2022 Q4 | -2.53 Billion CNY | -1.48% |
2022 Q2 | -1.05 Billion CNY | 53.16% |
2021 Q2 | -671.37 Million CNY | 11.15% |
2021 FY | -836.27 Million CNY | -12.14% |
2021 Q3 | -453.54 Million CNY | 32.44% |
2021 Q1 | -755.62 Million CNY | -1.32% |
2021 Q4 | -836.27 Million CNY | -84.38% |
2020 Q4 | -745.75 Million CNY | -598.17% |
2020 Q1 | 314.1 Million CNY | 27.07% |
2020 FY | -745.75 Million CNY | -401.69% |
2020 Q2 | 179.07 Million CNY | -42.99% |
2020 Q3 | 149.7 Million CNY | -16.4% |
2019 Q3 | 105.93 Million CNY | -15.45% |
2019 FY | 247.19 Million CNY | -8.27% |
2019 Q4 | 247.19 Million CNY | 133.35% |
2019 Q2 | 125.29 Million CNY | -63.7% |
2019 Q1 | 345.13 Million CNY | 28.07% |
2018 FY | 269.47 Million CNY | 285.74% |
2018 Q4 | 269.47 Million CNY | 216.56% |
2018 Q1 | 142.22 Million CNY | 103.58% |
2018 Q2 | 89.37 Million CNY | -37.16% |
2018 Q3 | 85.12 Million CNY | -4.75% |
2017 Q3 | 65.1 Million CNY | 23.86% |
2017 Q4 | 69.85 Million CNY | 7.31% |
2017 FY | 69.85 Million CNY | 150.38% |
2017 Q2 | 52.56 Million CNY | 803.03% |
2017 Q1 | 5.82 Million CNY | 104.2% |
2016 Q1 | -132.74 Million CNY | 39.31% |
2016 Q4 | -138.66 Million CNY | -37.36% |
2016 Q3 | -100.95 Million CNY | 38.26% |
2016 Q2 | -163.51 Million CNY | -23.18% |
2016 FY | -138.66 Million CNY | 36.61% |
2015 FY | -218.73 Million CNY | -233.27% |
2015 Q4 | -218.73 Million CNY | -27.63% |
2015 Q3 | -171.38 Million CNY | 21.14% |
2015 Q2 | -217.31 Million CNY | -662.64% |
2015 Q1 | 38.62 Million CNY | 158.85% |
2014 Q4 | -65.63 Million CNY | 0.0% |
2014 FY | -65.63 Million CNY | -161.65% |
2013 FY | -25.08 Million CNY | -201.93% |
2012 FY | 24.61 Million CNY | -38.24% |
2011 FY | 39.84 Million CNY | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Cachet Pharmaceutical Co., Ltd. | 1.13 Billion CNY | 334.07% |
Yixintang Pharmaceutical Group Co., Ltd. | 1.21 Billion CNY | 319.133% |
Luyan Pharma Co.,Ltd. | 4.23 Billion CNY | 162.648% |
Ji Yao Holding Group Co., Ltd. | 1.42 Billion CNY | 286.686% |